Pharmaceutical companies must first protect the market and welcome customers

According to medical agents, some pharmaceutical companies have focused their efforts on how to deal with customers. This is obviously inappropriate. Because customers have a sense of mistrust of drug companies, they will be detrimental to future cooperation. Pharmaceutical companies should first protect the market and ensure market stability is the basis for cooperation. For the understanding of the pharmaceutical investment agency market from the perspective of development, we must affirm that the products are from scratch, whether it is the development of science and technology is the progress of society. Many factors will be considered in the process of investment promotion for pharmaceutical companies.

Experts from the China Merchants Investment Network said that each of the business investment personnel of the company can understand the market, understand the business, and truly assist the agents in their business development. Under this kind of thinking, under the guidance of pharmaceutical companies, according to the different channels of agents, the agents will be divided into different channels, detailed study of the channel business strategy to do a good job of the business support of agents, and take the road of specialization. Pharmaceutical investment promotion itself is a kind of social activity. Enterprises must undertake corresponding social responsibilities and achieve a win-win situation among customers, shareholders, employees, and society. This requires that pharmaceutical investment enterprise operators have a rational and correct mentality for investment promotion to carry out investment promotion work. .

The position of pharmaceutical investment merchants in the industry, the positioning of the pharmaceutical investment model, and the positioning of individual roles. We will be cautious when signing relevant agreements with customers. We hope that customers will see their own sincerity and hope to control investment customers to some extent. In order to encourage and restrain customers, this pharmaceutical investment enterprise will achieve its own goals through a variety of different ways, such as signing effective contracts and agreements, and even requiring customers to pay certain deposits.

The pharmaceutical companies’ investment is to make full use of various methods and social resources for investment promotion and market development in medicine, and to provide medicines and services to the market, closely linking raw manufacturers, distributors and retailers to achieve mutual benefits and create links. The most benefits. The development of investment enterprises must also pay close attention to the direction of the policy and follow the trend. In view of the different policy guidance of the new medical reform on the three terminals in the current pharmaceutical industry, enterprises that are determined to carry out pharmaceutical investment products in different channels will have to profoundly study the policy directions and the resulting changes in the entire channel to the impact of pharmaceutical investment enterprise operations. For example, in clinical channels.